Ontario to announce plan for how to use remaining AstraZeneca COVID-19 vaccine
Published
Ontario public health officials are set to decide whether to use the province’s remaining inventory of AstraZeneca COVID-19 vaccine, after concerns about rare blood clot side effects prompted a pause on their use.
Full Article